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BACKGROUND: Until recently, it has been considered essential to maintain the use of a double-
limb circuit in patients with amyotrophic lateral sclerosis (ALS) to avoid rebreathing expired air
during invasive mechanical ventilation. Currently, life-sustaining home ventilators can work with
a single, lighter circuit that is easier to manage. Our aim was to evaluate the effectiveness and safety
of a single-limb circuit with intentional leaks (passive circuit) in comparison with a circuit with an
expiratory valve (active circuit), in subjects with ALS who use invasive home ventilation. METHODS:
We conducted a retrospective single-center study. The enrolled subjects were divided into 2 groups
according to the type of exhalation port. The aim of the study was to compare arterial blood gases;
nocturnal oxygen saturation recordings; and the occurrence of adverse events, both clinical and
technical events. In addition, we compared the rate of mortality and unplanned hospital admissions
that occurred within a year after discharge from the hospital. RESULTS: Forty-three subjects were
included in our study: 23 who used a passive circuit and 20 who used an active circuit. No significant
difference in nocturnal and diurnal gas exchanges was detected. The incidence of adverse events
was significantly higher in the active circuit group (85% in active circuit vs 30% in passive circuit,
P < .001). However, by splitting the adverse events into 2 categories, clinical and technical, the
technical events were significantly more frequent in the active circuit group. None of these events
led to hospital admission or death. CONCLUSIONS: The passive circuit was shown to be as
effective and safe as the active circuit during home invasive ventilation in the subjects with amyo-
trophic lateral sclerosis. A future randomized controlled study is necessary to confirm these results
and to extend indications to other pathologies. Key words: mechanical ventilation; chronic respiratory
failure; tracheostomy; respiratory therapy; neuromuscular diseases; amyotrophic lateral sclerosis (ALS).
[Respir Care 2018;63(9):1132–1138. © 2018 Daedalus Enterprises]
Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegen-
erative disease that leads to the progressive loss of motor
neuron function and, ultimately, to death. Respiratory fail-
ure occurs in different stages of the disease, which usually
represents the main cause of death.1 When continuous non-
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invasive ventilation is necessary 24 h/day or severe bulbar
involvement occurs, tracheostomy and invasive mechani-
cal ventilation should be considered.2 Invasive mechanical
ventilation in patients with ALS is considered life sustain-
ing; the patient’s life depends on the mechanical ventilator
functioning correctly. Since the 1980s, technological ad-
vances in the field of mechanical ventilation and the in-
creasing use of noninvasive ventilation allowed the cre-
ation of more sophisticated ventilators that became
increasingly more compact, portable, and easy to use, and
with safety and performance profiles similar to ICU ven-
tilators. At present, home ventilators can generally operate
with a single-limb circuit, even in cases of invasive me-
chanical ventilation, which facilitates both the patient’s
management and mobilization.
According to the type of exhalation port, there are 2
types of single-limb circuits: an active circuit, with a true
expiratory valve that directs all of the expired air out of
the circuit; and a passive circuit, with a calibrated in-
tentional leak placed proximal to the patient (Fig. 1).
The passive circuit, with continuous flow into the cir-
cuit, was found to be as effective as the active circuit in
avoiding rebreathing, even in cases of subjects who are
hypercapnic and using noninvasive ventilation.3 Cur-
rently, several home mechanical ventilators have been
cleared by the FDA and have received the European
declaration of conformity to be used as life-sustaining
devices during invasive mechanical ventilation, which
can be applied with both circuits.
However, to our knowledge, no data on the safety of
passive circuits during invasive mechanical ventilation are
available in the literature; in particular, there are no studies
that address the potential presence of rebreathing phe-
nomena or efficacy of airway humidification, or the
occurrence of technical problems. The aim of our study
was to compare data obtained during a 1-y period about
the safety and effectiveness of both active and passive
circuits, in subjects with ALS and who, at home, were
tracheostomized and using invasive ventilation with a
single-limb circuit.
Methods
We conducted a retrospective single-center study from
January 2012 to December 2014, which included patients
with ALS referred to the NEuroMuscular Omnicentre Cen-
ter in Milan. The study was approved by the Italian ethics
committee Milan Area C (protocol 242–062016). We en-
rolled all patients who fit the following criteria: (1) a
diagnosis of ALS, performed according to the El-Esco-
rial revised and Awaji criteria4-6; (2) treatment with
invasive mechanical ventilation started in our center
after a recent tracheostomy; (3) the need for mechanical
ventilation for 18 h/d; (4) use of a single-limb circuit;
(5) the prevalent use of closed ventilation through a
cuffed tracheostomy tube; and (6) regular follow-up, at
least once a year, performed according to the standards
of our center.
The enrolled subjects were divided into the following 2
groups on the basis of the exhalation port used with each
circuit: the passive circuit group and the active circuit
group. The choice of the 2 types of exhalation ports was
essentially driven by the following criteria. The subjects
who were already using a “life support” ventilator for
noninvasive ventilation at home were switched to invasive
ventilation while maintaining the same ventilator and the
same type of circuit. For the remaining subjects, the
ventilator was chosen among those already available at
home, preferably a passive circuit. For all the subjects,
the pressure control mode, with or without target vol-
ume, was used. Optimal ventilation parameters were set
by monitoring diurnal arterial blood gases and nocturnal
oxygen saturation as well as according to the subject’s
tolerance.
Humidification during invasive ventilation was provided
to all the subjects through a high-performance active hu-
midifier (Model MR850, Fisher and Paykel Healthcare,
Auckland, New Zealand). To enable the subjects to use a
wheelchair, they received humidification with a heat and
moisuture exchanger for a maximum of 4 h/d. All the
subjects received ventilation through cuffed, non-fenes-
trated tracheostomy tubes with an inner cannula. All the
subjects’ caregivers participated in a theoretical and prac-




Invasive mechanical ventilation is usually performed
with a double-limb circuit. The majority of life-sustain-
ing home ventilators can work with a single limb by
using either an expiratory valve (active circuit) or a
calibrated intentional leak (passive circuit). The passive
circuit may expose patients to carbon dioxide rebreath-
ing, or to ineffective airway humidification. However,
both circuits can also be used in invasive ventilation.
What this paper contributes to our knowledge
The use of the passive circuit during invasive mechan-
ical ventilation in the home in subjects with ALS was
not inferior to the active circuit in providing adequate
correction of respiratory gas exchange and in maintain-
ing a similar profile of safety. Moreover, the passive
circuit seemed to be related to a significantly lower
number of technical problems.
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In our center, for all patients with ALS discharged
with invasive mechanical ventilation, we suggest fol-
low-up visits at least twice a year. During the follow-up,
arterial blood gases and nocturnal pulse oximetry were
measured. Moreover, the caregivers were asked to fill
out a diary that reported the occurrence of respiratory
infections that needed medical interventions; unplanned
hospital admissions; deaths; and adverse events, which
were classified into clinical events and technical events,
related to invasive mechanical ventilation. Clinical
events were represented by the acute occlusion of the
tracheal cannula, tracheal wall instability that required
variation in the tracheostomy tube model, massive tra-
cheal bleeding, and cannula damage. Technical events
were represented by urgent, unplanned technical inter-
ventions for ventilator malfunctioning, and unplanned
circuit or ventilator replacements for a technical failure.
The adverse event rate consisted of the number of sub-
jects who reported at least one clinical event or techni-
cal event during the 1-y follow-up. Data related to the
technical events (urgent technical interventions and re-
placements) were confirmed by home-care providers of
all subjects involved in the study.
For all the subjects who met the inclusion criteria, we
collected and analyzed arterial blood gases and data
from nocturnal pulse oximetry at discharge from the
hospital (T0), after 4 – 6 months (T1), and after 1 y (T2).
All recorded data from discharge to T2 on respiratory
infections, hospital admissions, deaths, and adverse
events were collected. Our primary outcome was to com-
pare gas exchange, adverse events, and respiratory in-
fection rates between the passive and the active circuit
groups. Our secondary outcome was to compare mor-
tality and hospital admissions that occurred within 1 y
from the hospital discharge.
Statistical Analysis
All analyses were conducted by using SAS 9.3 (SAS
Institute, Cary, North Carolina). Data were reported in the
text and tables as mean  SD or median (interquartile
range), as appropriate for continuous variables, and as the
number and percentage for non-continuous variables. The
variable adverse event was reported as dichotomous: cat-
egory 0, subjects who had no adverse events; and category
1, subjects who reported at least one adverse event during
the 1-y follow-up. For each variable, we used the Shapiro-
Wilk test to evaluate the normality of the distribution and
the Levene test to evaluate the homogeneity of variance.
Our primary and secondary outcomes were investigated by
using the t test, Wilcoxon rank-sum test, Kruskal-Wallis
test, chi-square test, and Fisher exact test, as appropriate.
Tests were 2-tailed, and a P  .05 was considered statis-
tically significant and was adjusted by using the Bonfer-
roni correction when appropriate. A multivariable Cox pro-
portional hazard model was used to determine whether the
type of circuit was independently related to survival and
when adjusting for age and setting, with statistical signif-
icance at P .05.
Results
From January 2012 to December 2014, a total of 53
subjects with ALS were started on invasive mechanical
ventilation while in our center. Ten subjects were excluded
from the analysis because they did not perform the fol-
low-up in our center; therefore, 43 subjects were included
in the study: 23 subjects in the passive circuit group and
20 in the active circuit group. The characteristics of the
study population are shown in Table 1. The 2 groups
were homogeneous for sex, type of onset and disease
phenotype, total number of follow-up visits, and dom-
A B
Fig. 1. Passive circuit with intentional leak (A) and active circuit with expiratory valve (B).
PASSIVE VS ACTIVE CIRCUIT VENTILATION IN SUBJECTS WITH ALS
1134 RESPIRATORY CARE • SEPTEMBER 2018 VOL 63 NO 9
iciliary status. The passive circuit group significantly
differed from the active circuit group for mean  SD
age at disease onset (54.6  12.4 y vs 63.8  8.6 y,
respectively, P  .008) and for mean  SD age at
tracheostomy (58.7  11.4 y vs 67.8  9.2 y, respec-
tively, P  .007).
All of the subjects in the passive circuit group were re-
ceiving ventilation with Trilogy 100 (Philips Respironics,
Murrysville, Pennsylvania), whereas, in the active circuit
group, the ventilators used were Elise`e 150 (ResMed SA,
Saint Priest, France; 7 subjects); Vivo 50 (Breas Medical AB,
Mölnlycke, Sweden; 2 subjects); Puritan Bennet 560 (Covi-
dien llc, Mansfield, Massachussetts; 4 subjects); and Monnal
T50 (Air Liquide Medical Systems, Antony, France; 7 sub-
jects). All the subjects were using ventilation in the pressure
controlled mode: 78% of subjects in the passive circuit group
versus 55% in the active circuit group with the addition of a
target volume. During the first year, the ventilation mode
remained unchanged for most of the subjects (82.6% in the
passive circuit group vs 95% in the active circuit group). The
majority of the subjects were using ventilation with an FIO2 of
0.21 (78.3% in the passive circuit group vs 75% in the active
circuit group). The parameters used during invasive mechan-
ical ventilation are reported in Table 2.
The passive and active circuits were equally effective in
correcting nocturnal and diurnal oxygenation, as shown in
Table 2. Furthermore, only in the passive circuit group, we
found a significant improvement of PaO2 at T1 and T2
compared with T0 (Table 3), with no change in the FIO2
during the same period of time.
The adverse event rate was significantly higher in the
active circuit than in the passive circuit group (85% vs
30.5% respectively, P  .001). However, when dividing
the adverse events into 2 categories, clinical events and
technical events, only the technical events were found to
be significantly more frequent in the active circuit group,
as shown in Table 4. The number and distribution of clin-
ical events related to invasive mechanical ventilation are
described in e-Table 1 (see the supplementary materials at
http://www.rcjournal.com). None of these events led to
hospital admission or death. There was no difference be-
tween the 2 groups in terms of respiratory infection rate,
hospital admissions, and deaths (Table 5). The analysis for
1-y survival did not show any differences between the 2
groups (hazard ratio  1.11, P  .88).
Discussion
To our knowledge, these were the first clinical data on
the efficacy and safety of the use of a passive circuit
Table 1. Subject Characteristics
Characteristics Passive CircuitGroup (n  23)
Active Circuit
Group (n  20)
Male/female, n 13/10 11/9
Age at onset, mean  SD y 54.6  12.4 63.8 8.6*
Age at tracheostomy, mean  SD y 58.7  11.4 67.8 9.2*
Months from onset to tracheostomy,
median (IQR)
45 (28–52) 40 (29–49)
Type of onset, n (%)
Lower limb 11 (47.83) 8 (40.00)
Upper limb 6 (26.09) 7 (35.00)
Bulbar 6 (26.09) 3 (15.00)
Generalized 0 (0) 1 (5.00)
Respiratory 0 (0) 1 (5.00)
Disease phenotype, n (%)
Bulbar 3 (13.04) 0 (0)
Classic 17 (73.91) 16 (80.00)
Flail arm 1 (4.35) 0 (0)
PLMN 1 (4.35) 2 (10.00)
PUMN 0 (0) 1 (5.00)
Pyramidal 1 (4.35) 1 (5.00)
Follow-up, n (%)
 4 7 (30.43) 7 (35.00)
4–8 13 (56.52) 6 (30.00)




* The difference between passive and active circuit groups, P  .01.
IQR  interquartile range
PLMN  pure lower motor neuron
PUMN  pure upper motor neuron
Table 2. Ventilation Parameters and Gas Exchange at Discharge
From the Hospital
Parameters Passive CircuitGroup (n  23)
Active Circuit
Group (n  20) P
Minimum pressure support,
cm H2O
13 (11–15) 14 (11–15) .92
Maximum pressure support,
cm H2O
16 (15–18) 19 (16–25) .10
Pressure support, cm H2O 16 (15–18) 15 (13–16) .40
EPAP, cm H2O 6 (5–6) 6 (5–6) .82
VT, mL 500 (500–550) 500 (500–500) .30
Mean nocturnal SpO2 % 97 (60–98) 97 (95–98) .49
ODI 0.10 (0–0.40) 0.30 (0–0.65) .33
T90, % 0.1 (0–0.1) 0.1 (0–0.1) .53
FIO2 0.21 (0.21–0.21) 0.21 (0.21–0.24) .11
PaO2, mm Hg 83 (75–88) 83 (78–93) .72
PaCO2, mm Hg 30 (26–32) 30 (28–34) .54
pH 7.51 (7.49–7.55) 7.50 (7.47–7.54) .45
HCO3, mEq/L 25 (23–28) 24 (23–28) .97
All variables are reported as median (interquartile range).
EPAP  expiratory positive airway pressure
VT  tidal volume
ODI  oxygen desaturation index
T90  percentage of time spent with SpO2  90% at night
PaO2  partial pressure of oxygen
PaCO2  partial pressure of carbon dioxide
HCO3  bicarbonate
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during invasive mechanical ventilation in any patients. So
far, the 2 different exhalation ports have been evaluated
only in bench studies7,8 or in a clinical setting during non-
invasive ventilation.7 Our results indicated that the passive
circuit was as effective as the active circuit in eliminating
carbon dioxide and in correcting gas exchange when treat-
ing subjects with ALS by using invasive mechanical ven-
tilation and that this effectiveness was maintained over
time. However, none of our subjects had chronic pulmonary
disease as a comorbidity that could lead to hypercapnia. For
this reason, these results cannot be extended to other patients
receiving invasive ventilation for chronic hypercapnic respi-
ratory failure. Moreover, we used expiratory positive airway
pressure values higher than those suggested in the literature
as the minimum required,9 and this may, in part, explain the
effectiveness of CO2 washout, even when using a passive
circuit. However, expiratory positive airway pressure levels
were not significantly different between the 2 groups.
We found a significant improvement of PaO2 over time
only in the passive circuit group, despite no increase in
FIO2 and no changes in the mechanical ventilation param-
eters. The difference in age at disease onset and at trache-
ostomy could explain the improvement in gas exchange in
the passive circuit group; indeed, this could promote a
better response to mechanical ventilation (eg, better lung
recruitment) in younger patients with less compromised
ventilation/perfusion matching. Moreover, younger pa-
tients may be prone to spend more time in a sitting posi-
tion, which allows a postural lung recruitment.
The incidence of chest infections, unplanned admissions
for acute respiratory events, and deaths after 1 y did not differ
between the 2 groups, whereas the incidence of adverse ef-
fects was significantly higher in the active circuit group com-
pared with the passive circuit group, particularly in terms of
Table 3. Arterial Blood Gases
Parameters T0 T1 T2 P
Passive circuit group
FIO2 0.21 (0.21–0.21) 0.21 (0.21–0.21) 0.21 (0.21–0.21) .44
PaO2, mm Hg 83 (75–88) 99 (88–104) 96 (85–105) .001
PaCO2, mm Hg 30 (26–32) 27 (24–32) 27 (23–34) .71
pH 7.51 (7.49–7.55) 7.52 (7.49–7.55) 7.54 (7.50–7.57) .56
HCO3, mEq/L 25 (23–28) 24 (22–25) 23 (21–27) .42
Active circuit group
FIO2 0.21 (0.21–0.24) 0.21 (0.21–0.21) 0.21 (0.21–0.21) .68
PaO2, mm Hg 83 (78–93) 97 (85–99) 95 (88–105) .16
PaCO2, mm Hg 30 (28–34) 29 (27–35) 28 (24–35) .55
pH 7.50 (7.47–7.54) 7.51 (7.49–7.54) 7.53 (7.48–7.59) .44
HCO3, mEq/L 24 (23–28) 26 (22–28) 24 (20–27) .53
Data of all variables are reported as median (interquartile range).
T0  at discharge from the hospital
T1  after 4–6 mo
T2  after 1 y
PaO2  partial pressure of oxygen
PaCO2  partial pressure of carbon dioxide
HCO3  bicarbonate
Table 4. The Incidence of Adverse Events due to Invasive
Mechanical Ventilation
Adverse Event Passive CircuitGroup
Active Circuit
Group P
Adverse event rate* 7 (30) 17 (85)  .001
Clinical events† 6 5 .93
Technical events† 3 14 .003
* The number (percentage) of the subjects who reported at least one clinical or technical event
during the 1-y follow-up.
† The total number of events for each group.
Table 5. Acute Medical Events
Acute Medical Event Passive CircuitGroup
Active Circuit
Group P
Acute chest infections, n (%) .42
0 7 (30.43) 9 (45.00)
1 6 (26.09) 6 (30.00)




0 15 (65.22) 10 (50.00)
1 5 (21.74) 7 (35.00)
 1 3 (13.04) 3 (15.00)
Deaths at 1 y, n (%) 4 (36.36) 4 (50.00) .55
Months from tracheostomy to
death, mean  SD
17.04  10.36 16.04  10.06 .84
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the number of ventilator replacements for technical failure.
However, no deaths were due to adverse events.
Risk management is a key aspect to be considered in
patients who are using a ventilator at home. Our definition
of adverse events was in line with other studies.10,11 How-
ever, the design of our study did not allow us to establish
a cause-effect relationship between these data and the type
of circuit used. Nevertheless, in our clinical experience,
several episodes of technical failure are due to the con-
densation accumulated on the membrane of the active ex-
halation port, so we could speculate that this might explain
the occurrence of more frequent technical problems, which
requires the replacement of the ventilator in the active
circuit group. Unfortunately, the retrospective design of
our study and of the data supplied by home-care providers
did not allow us to establish whether the recorded techni-
cal problems were related to the circuit or to the ventilator.
Moreover, the higher age at disease onset and at the time
of tracheotomy in the active circuit group itself might have
contributed to the increased incidence of complications in
the active circuit group. Irrespective of the possible rea-
sons that caused this finding, we could still assert that the
use of a passive circuit in these subjects was not inferior to
the active one in terms of technical and clinical compli-
cations.
Humidification effectiveness during invasive mechani-
cal ventilation is mandatory to prevent dryness and dam-
age to the mucosa of the respiratory tract and to avoid
reduced secretion clearance.12-15 In our cohort, there were
no differences in the incidence of tracheostomy tube oc-
clusions or other acute respiratory complications. This ex-
tremely important finding indicated that, despite the pres-
ence of an intentional leak in the passive circuit, a variable
loss of active humidification did not compromise the clin-
ical safety of these subjects.
The use of a passive circuit may offer several advan-
tages compared with the active circuit. The passive circuit
is lightweight and simple to use, and has lower expiratory
resistance. Furthermore, the passive circuit offers an im-
portant advantage when using the pressure controlled mode
with a target volume during uncuffed open ventilation,
which allows the patient with preserved bulbar function to
speak during invasive mechanical ventilation.16 In fact, as
shown in a recent bench study,17 during volume-targeted
pressure control mode, in the presence of non-intentional
leaks, the active circuit fails to maintain the target volume,
which shows a clinically relevant fall in inspiratory pres-
sure, whereas the passive circuit is able to guarantee this
volume, even in cases of very high leaks.
This study had limitations. Some of these limitations
arose from the study’s retrospective nature. In addition, it
was partially based on information obtained from the med-
ical history collected from the subjects and caregivers and
on data supplied by home-care providers, which may not
have been sufficient for interpretation. The small size of
our sample was, in part, due to the relatively recent intro-
duction in Europe of passive circuits for invasive mechan-
ical ventilation use. This could have reduced the power of
the study and prevented us from stratifying the analysis to
detect potential confounding variables.
Conclusions
We found that the use of the passive circuit during home
invasive mechanical ventilation in the subjects with ALS
was not inferior to the use of the active circuit in assuring
a good correction of respiratory gas exchange and in main-
taining a similar profile of safety. Moreover, the passive
circuit seemed to be related to a significantly lower num-
ber of technical problems. However, these data must be
confirmed in a future randomized controlled study specif-
ically designed to compare the 2 different circuits and to
possibly extend these results to other pathologies.
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